RBM15 and chronic myelogenous leukemia, BCR-ABL1 positive: Reducing RBM15 expression level by RNA interference could inhibit the growth and proliferation of chronic myelogenous leukemia cells, block the cell cycle, and induce apoptosis (Y. Yang et al., 2012).